Understanding Immune Responses to Optimize Immune Intervention

Thursday, April 16, 2026

9:45 AM - 11:15 AM US ET

Location: 156

Moderator(s)

9:45 AM - 10:00 AM US ET

Understanding unconventional T cell development to generate an ‘off the shelf’ immunotherapy to treat human diseases
Author: Daniel Pellicci, PhD – Murdoch Children's Research Institute
10:00 AM - 10:15 AM US ET

Single-cell buoyant mass reveals CD8⁺ T-cell fitness and predicts melanoma checkpoint response
Author: JIAQUAN YU, PhD – Koch Inst. for Integrative Cancer Res., MIT
10:15 AM - 10:30 AM US ET

Single Cell Insights on Inflammation-Induced Transitional States in Benign Prostate Hyperplasia
Author: Nikhila T. Suresh, PhD (she/her/hers) – Florida Atlantic University
10:30 AM - 10:45 AM US ET

Optimizing Cancer Antibody Effectiveness: Pharmacology and Mathematical Modeling to Achieve Better Clinical Outcomes
Author: Denise Faustman, MD, PhD – Massachusetts General Hospital/Harvard Medical School
10:45 AM - 11:00 AM US ET

Morning influenza vaccination elicits superior antigen-specific immune responses in adults aged 60-85 years
Author: Tamara Brouwers, MSc (she/her/hers) – Dutch National Institute for Public Health and the Environment
11:00 AM - 11:15 AM US ET

BCG vaccine induces distinct metabolic shifts in monocytes in vitro and peripheral blood plasma in vivo: Implications for neonatal trained immunity
Author: Asimenia Angelidou, MD, PhD (she/her/hers) – Boston Children's Hosp., Harvard Med. Sch.